Singapore markets closed

Acutus Medical, Inc. (AFIB)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0590+0.0140 (+31.11%)
At close: 03:49PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0450
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0415 - 0.0728
52-week range0.0360 - 0.9900
Avg. volume1,217,960
Market cap1.754M
Beta (5Y monthly)0.25
PE ratio (TTM)N/A
EPS (TTM)-0.4100
Earnings date05 Aug 2024 - 09 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Acutus Medical Reports First Quarter 2024 Financial Results

    CARLSBAD, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the first quarter of 2024. Recent Highlights: First quarter revenue from Continuing Operations of $3.6 million grew 192% year-over-year, from $1.2 million in the same quarter last year..Operating expenses for continuing operations were $3.3 million, a reduction of 38% compared to the same period last year.Recorded $2.8 million in gain on sale of business, an

  • Simply Wall St.

    Acutus Medical Full Year 2023 Earnings: US$0.41 loss per share (vs US$1.40 loss in FY 2022)

    Acutus Medical ( NASDAQ:AFIB ) Full Year 2023 Results Key Financial Results Revenue: US$7.16m (down 56% from FY 2022...

  • GlobeNewswire

    Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results

    CARLSBAD, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the fourth quarter and full year ended December 31,2023. Recent Highlights: Announced strategic realignment of resources and corporate restructuring on November 8, 2023 with the objective of optimizing financial position and maximizing free cash flow.The Continuing Operations focuses on the implementation of the business model to shift to solely support